PacificGMP and Pacific Biopharma Group (PBG) have signed a definitive merger agreement and will develop a cGMP biologics CMO in Taizhou, China. At approximately 200,000 sq. ft., the new CMO, called China Quantitative Biomedicine (CQB), will be one of the largest single-use biomanufacturing facilities in the U.S. or China, according to a company statement. Construction of the facility in Taizhou is expected to be completed in August 2008 with internal construction and equipment installation expec...